文献速递血栓与止血

PTPRJ功能缺失突变导致一种新型遗传性血小板减少症

Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia.
PubMed 文献 · Blood · 2018-12-27

通过对2例常染色体隐性遗传性血小板减少症同胞进行外显子测序,鉴定出PTPRJ双等位基因功能缺失变异;患者血小板和巨核细胞中PTPRJ几乎完全缺失,斑马鱼ptprja敲除及患者巨核细胞体外实验均显示血小板生成受损。该病表现为非综合征性血小板减少症,伴自发性出血、血小板体积小及对GPVI激动剂反应受损。

要点

  • PTPRJ双等位基因功能缺失变异可导致常染色体隐性遗传性血小板减少症。
  • 患者表现为非综合征性血小板减少症,伴自发性出血、血小板体积小及对胶原和convulxin反应受损。
  • PTPRJ在血小板生成中起重要作用,其缺陷导致巨核细胞成熟障碍、SDF1驱动迁移及前血小板形成缺陷。

核心结论

  • PTPRJ功能缺失突变导致一种新型遗传性血小板减少症,并揭示PTPRJ在血小板生成中此前未知的基本作用。

研究设计与样本

  • 对2例常染色体隐性遗传性血小板减少症同胞进行外显子测序,并开展斑马鱼CRISPR/Cas9敲除、患者巨核细胞体外功能实验及人巨核细胞系PTPRJ沉默实验。

主要发现

  • 2例患者均携带PTPRJ双等位基因功能缺失变异,其信使RNA和蛋白水平上PTPRJ几乎完全缺失。
  • 斑马鱼中CRISPR/Cas9介导的ptprja敲除导致体内CD41+血栓细胞数量显著减少。
  • 患者巨核细胞体外显示成熟受损以及SDF1驱动的迁移和前血小板形成严重缺陷。
  • 在人巨核细胞系中沉默PTPRJ可重现患者巨核细胞观察到的功能缺陷。
  • 患者血小板对GPVI激动剂胶原和convulxin的反应受损,归因于Src家族激酶活化降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inherited thrombocytopenias (ITs) are a heterogeneous group of disorders characterized by low platelet count that may result in bleeding tendency. Despite progress being made in defining the genetic causes of ITs, nearly 50% of patients with familial thrombocytopenia are affected with forms of unknown origin. Here, through exome sequencing of 2 siblings with autosomal-recessive thrombocytopenia, we identified biallelic loss-of-function variants in PTPRJ . This gene encodes for a receptor-like PTP, PTPRJ (or CD148), which is expressed abundantly in platelets and megakaryocytes. Consistent with the predicted effects of the variants, both probands have an almost complete loss of PTPRJ at the messenger RNA and protein levels. To investigate the pathogenic role of PTPRJ deficiency in hematopoiesis in vivo, we carried out CRISPR/Cas9-mediated ablation of ptprja (the ortholog of human PTPRJ) in zebrafish, which induced a significantly decreased number of CD41+ thrombocytes in vivo. Moreover, megakaryocytes of our patients showed impaired maturation and profound defects in SDF1-driven migration and formation of proplatelets in vitro. Silencing of PTPRJ in a human megakaryocytic cell line reproduced the functional defects observed in patients' megakaryocytes. The disorder caused by PTPRJ mutations presented as a nonsyndromic thrombocytopenia characterized by spontaneous bleeding, small-sized platelets, and impaired platelet responses to the GPVI agonists collagen and convulxin. These platelet functional defects could be attributed to reduced activation of Src family kinases. Taken together, our data identify a new form of IT and highlight a hitherto unknown fundamental role for PTPRJ in platelet biogenesis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Marconi C, Di Buduo CA, LeVine K, et al. Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia. Blood. 2018. PMID: 30591527. doi:10.1182/blood-2018-07-859496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。